Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Scheie

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Acta Neuropathologica|November 23, 2024
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsJelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica|January 3, 2025
Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsJelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2025
Childhood Cancer Predisposition and Evolutionary Constraints: Novel lessons from Germline Genomes from 1,127 Children with CancerUlrik Kristoffer Stoltze, Thomas van Overeem Hansen, Jon Foss-Skiftesvik, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Acta Neurochirurgica|April 6, 2026
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patientsChristian Mirian, Lasse Rehné Jensen, Tareq A Juratli, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Acta Neuropathologica|November 23, 2024
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsJelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica|January 3, 2025
Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsJelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2025
Childhood Cancer Predisposition and Evolutionary Constraints: Novel lessons from Germline Genomes from 1,127 Children with CancerUlrik Kristoffer Stoltze, Thomas van Overeem Hansen, Jon Foss-Skiftesvik, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Acta Neurochirurgica|April 6, 2026
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patientsChristian Mirian, Lasse Rehné Jensen, Tareq A Juratli, et al.
Pageof 12